DGAP-News: Fresenius Medical Care AG & Co. KGaA Makes Strategic Investments in Care Coordination

Fresenius Medical Care AG & Co. KGaA Makes Strategic Investments in Care Coordination

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Schlagwort(e):

Sonstiges

Fresenius Medical Care AG & Co. KGaA Makes Strategic Investments in

Care Coordination

27.06.2014 / 09:25

---------------------------------------------------------------------

Company executes on the strategy disclosed earlier this year to invest in

care coordination around dialysis. The investment clearly advances the

commitment to address the full spectrum of care for chronically ill

patients.

Bad Homburg, Germany - Fresenius Medical Care AG & Co. KGaA (the "company"

or "Fresenius Medical Care"; Frankfurt Stock Exchange: FME / New York Stock

Exchange: FMS), the world's largest provider of dialysis products and

services, has entered into an agreement to invest approximately $600

million in Sound Inpatient Physicians, Inc. (www.soundphysicians.com) to

become majority shareholder as part of a recapitalization of Sound,

alongside existing investor TowerBrook Capital Partners and Sound's senior

leadership team. The transaction is subject to customary closing conditions

and is expected to close within the next ten days.

Sound Physicians has grown rapidly to more than 1,000 physician partners

providing care in over 100 hospitals and post-acute care centers across the

United States. It has pioneered a consistent, patient-centered approach

that relies on experienced physician leadership and a web-based workflow

platform. The focus on consistent processes and standards supporting highly

trained clinical experts positions Sound Physicians as the partner of

choice for efficient and effective performance throughout the acute and

post-acute episode of care.

"Fresenius Medical Care shares with Sound Physicians a long record of

improving health outcomes for patients and reducing costs to the health

care system," said Ron Kuerbitz, Chief Executive Officer of Fresenius

Medical Care North America. "This investment in Sound's inpatient expertise

is a significant step forward in our care coordination strategy and

augments our network of 2,150 dialysis clinics, 53 vascular care centers,

renal pharmacy and full service and specialty laboratories to help us

better address the full spectrum of our patients' health care needs. We

have a singular focus: improving the quality of life of every patient every

day. We believe the doctors and nurses at Sound Physicians share this

commitment and we are excited to partner with them to deliver better

results to patients."

"We are excited to have Fresenius Medical Care as our new strategic

partner," said Robert A. Bessler, MD, Sound's Chief Executive Officer.

"They bring decades of experience in managing chronic disease for dialysis

patients and have improved quality, patient satisfaction and reduced the

overall cost of care for this population. Their values and business goals

are closely aligned with Sound Physicians and our hospital partners. I look

forward to benefiting from their leadership in advancing innovation and

improvement in the acute episode of care in hospitals and post-acute arenas

throughout the U.S."

The Company expects Sound Physicians to generate approximately $500 million

in revenue in the next twelve months and expects the investment to be

accretive to operating earnings within the first year after closing,

subject to adjustment for transaction costs. It will fund the investment

through available cash and committed credit facilities, supplemented by

additional debt financing.

Fresenius Medical Care also disclosed that it has acquired MedSpring Urgent

Care Centers (www.medspring.com), with operations in Illinois and Texas.

MedSpring's 14 urgent care centers provide convenient, consistent,

high-quality primary care and customer service every day.

"MedSpring's commitment to providing primary care to patients where and

when they need it most is a critical component of a truly effective 21st

century health care network," said Kuerbitz. "We look forward to working

with them to help expand their existing footprint and continue to provide

patients with a more complete set of health care options."

"Every day, our associates succeed in delivering quality, cost-effective

care our patients love, and it shows in our satisfaction scores where we

receive 4.9 out of 5 stars," explained Jon Belsher, M.D., MedSpring's Chief

Medical Officer. "We are excited about the potential to continue to improve

patient care as part of the broader Fresenius Medical Care network."

About Fresenius Medical Care

Fresenius Medical Care is the world's largest integrated provider of

products and services for individuals undergoing dialysis because of

chronic kidney failure, a condition that affects more than 2.5 million

individuals worldwide. Through its network of 3,263 dialysis clinics in

North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius

Medical Care provides dialysis treatments for 270,570 patients around the

globe. Fresenius Medical Care is also the world's leading provider of

dialysis products such as hemodialysis machines, dialyzers and related

disposable products.

For more information about Fresenius Medical Care, visit the company's

website at www.fmc-ag.com.

Disclaimer

This release contains forward-looking statements that are subject to

various risks and uncertainties. Actual results could differ materially

from those described in these forward-looking statements due to certain

factors, including changes in business, economic and competitive

conditions, regulatory reforms, foreign exchange rate fluctuations,

uncertainties in litigation or investigative proceedings, and the

availability of financing. These and other risks and uncertainties are

detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the

U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co.

KGaA does not undertake any responsibility to update the forward-looking

statements in this release.

Ende der Corporate News

---------------------------------------------------------------------

27.06.2014 Veröffentlichung einer Corporate News/Finanznachricht,

übermittelt durch die DGAP - ein Unternehmen der EQS Group AG.

Für den Inhalt der Mitteilung ist der Emittent / Herausgeber

verantwortlich.

Die DGAP Distributionsservices umfassen gesetzliche Meldepflichten,

Corporate News/Finanznachrichten und Pressemitteilungen.

Medienarchiv unter http://www.dgap-medientreff.de und

http://www.dgap.de

---------------------------------------------------------------------

Sprache: Deutsch

Unternehmen: Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Straße 1

61352 Bad Homburg

Deutschland

Telefon: +49 (0) 6172- 609 2525

Fax: +49 (0) 6172- 609 2301

E-Mail: ir@fmc-ag.com

Internet: www.fmc-ag.de

ISIN: DE0005785802, DE0005785836,

WKN: 578580, 578583

Indizes: DAX

Börsen: Regulierter Markt in Frankfurt (Prime Standard);

Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover,

München, Stuttgart; Terminbörse EUREX; NYSE

Ende der Mitteilung DGAP News-Service

---------------------------------------------------------------------

275496 27.06.2014